| Code | CSB-MP004954HU1 |
| Abbreviation | Recombinant Human CD70 protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CD70, a TNF superfamily member that drives CD27-mediated co-stimulatory signaling on T and B cells, plays a critical role in anti-tumor immunity and has emerged as a therapeutic target in oncology. This recombinant human CD70 (residues 52–193) is expressed in mammalian cells with an N-terminal 10xHis tag, preserving native post-translational modifications essential for receptor engagement. Functional ELISA confirms binding activity with an EC50 of 2.414–3.196 ng/mL against anti-CD70 antibody, supporting use as a coating antigen for antibody development and validation, as a positive control in CD70 detection assays, and in NF-κB signaling pathway studies downstream of CD27 activation. Endotoxin levels below 1.0 EU/μg minimize LPS-driven artifacts in immune cell-based assays, while purity exceeding 90% by SDS-PAGE satisfies the quality thresholds commonly required for in vivo tumor biology models.
There are currently no reviews for this product.